2-Methyl-3-((7R,11R,E)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-diol

Catalog No. :
ACVSWO638
CAS No. :
572-96-3
Molecular Formula :
C31H48O2
Molecular Weight :
452.72

IUPAC Name:2-methyl-3-((7R,11R,E)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-diol

2-Methyl-3-((7R,11R,E)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-diol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-3-((7R,11R,E)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-diol
IUPAC Name2-methyl-3-((7R,11R,E)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-diol
MDL No.MFCD09840474
Molecular FormulaC31H48O2
Molecular Weight452.72
SMILESOC1=C2C=CC=CC2=C(O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C1C
InChI KeyBUFJIHPUGZHTHL-NKFFZRIASA-N
Synonym[R-[R*,R*-(E)]]-2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-diol;2-Methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenyl]-1,4-naphthalenediol;Dihydro Phytonadio;Dihydrovitamin K1;Vitamin K1 Hydroquinone;Dihydro Phytonadiol;2-Methyl-3-phytyl-1,4-naphthalenediol;Phyllohydroquinone
CAS No.572-96-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACVSWO638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVSWO638 route product structure diagram
    ACVSWO638572-96-3
Inquiry

2. ACVSWO638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVSWO638 route product structure diagram
    ACVSWO638572-96-3
Inquiry

Comments (0)